Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial

Published:2006-01 Issue:1 Volume:151 Page:92-99
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Serebruany Victor L.,Pokov Alex N.,Malinin Alex I.,O'Connor Christopher,Bhatt Deepak L.,Tanguay Jean-Francois,Sane David C.,Hennekens Charles H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors;Hennekens;Circulation,1998

2. How can cross-country research on health risks strengthen interventions? Lessons from INTERHEART;Ezzati;Lancet,2004

3. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report;Chobanian;JAMA,2003

4. The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression;Cushman;J Clin Hypertens,2003

5. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol;Dahlof;Lancet,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise;American Journal of Cardiovascular Drugs;2019-02-04

2. Acquired Disorders of Platelet Function;Hematology;2018

3. Aspirin in the elderly — tailored approaches ahead?;Nature Reviews Cardiology;2017-08-10

4. Antiplatelet Treatment in Essential Hypertension: Where Do We Stand?;Current Hypertension Reports;2015-03-20

5. Effect of Aliskiren and Valsartan Combination Versus Aliskiren Monotherapy on Hemostatic Biomarkers in Hypertensive Diabetics;American Journal of Therapeutics;2014-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3